USPTO serial 79316409
Reviewed by CopyMark Law Group
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical diagnostic test strips; test strips for measuring levels of blood glucose, cholesterol, triglycerides, heart markers or any other medical biology marker; immunological reagents for medical use | ACTIVE | — |
| 010 | Devices and apparatus for diagnosing, measuring, testing, levels of blood glucose, cholesterol, triglycerides, heart markers or any other medical biology marker; medical material for performing biological measurements on a reader for diagnosing and monitoring diseases; single use consumables enabling biological measurements to be conducted on a reader from different biological fluids (blood, urine, saliva), for medical and veterinary use | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 1, 2023 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 11, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 11, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 23, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 4, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 4, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 11, 2022 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 11, 2022 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 11, 2022 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 5, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 10, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 21, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 21, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 18, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 20, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 19, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 10, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 7, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 3, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 2, 2021 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jul 29, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |